4 free views remaining today

congenital myopathy 8

ICD-10 Codes

Related ICD-10:

Description

Early-Onset Muscle Weakness

Congenital myopathies, including centronuclear myopathy, are characterized by early-onset muscle weakness [7]. This condition typically begins in infancy or early childhood, with symptoms such as:

  • Weakness of the arms and legs
  • Droopy eyelids (ptosis)
  • Problems with eye movements

These symptoms can be present from birth, making congenital myopathies a rare genetic condition that affects muscle function.

Additional Characteristics

  • Droopy eyelids (ptosis)
  • Weakness of the arms and legs
  • Problems with eye movements

Signs and Symptoms

Common Signs and Symptoms of Congenital Myopathy

Congenital myopathies can cause a range of symptoms, which may vary depending on the specific type of condition. Some common signs and symptoms include:

  • Severe muscle weakness: This is one of the most common symptoms of congenital myopathy, affecting various parts of the body such as the face, arms, legs, and thighs.
  • Muscle cramps: Muscle cramps, stiffness, and spasm can occur in some cases of congenital myopathy.
  • Breathing difficulties: Some individuals with congenital myopathy may experience breathing problems due to muscle weakness affecting the respiratory muscles.
  • Scoliosis: Severe curvature of the spine (scoliosis) is a common feature in many cases of congenital myopathy.
  • Weak eye movements: Weakened eye movements can also be a symptom of some types of congenital myopathy.

These symptoms can vary in severity and may be present from birth or develop later in life. It's essential to consult with a healthcare professional for an accurate diagnosis and treatment plan.

References: [8] - Muscle cramps, stiffness, and spasm are mentioned as other symptoms of myopathy. [7] - Breathing difficulties and severe weakness of the limbs and scoliosis are also mentioned. [6] - Severe muscle weakness is a common symptom of congenital myopathies. [5] - A pattern of weak muscles that is most prominent in the face, arms, and legs is described.

Additional Symptoms

  • Scoliosis
  • Breathing difficulties
  • Muscle cramps
  • Severe muscle weakness
  • Weak eye movements

Diagnostic Tests

Diagnostic Tests for Congenital Myopathy

Diagnosing congenital myopathies requires a comprehensive approach that integrates data from various sources. The following diagnostic tests are commonly used to confirm the diagnosis:

  • Muscle biopsy: A muscle biopsy is a crucial test that helps identify specific structural and histochemical features associated with congenital myopathies [7]. This test involves removing a small sample of muscle tissue for examination under a microscope.
  • MRI of muscles: Magnetic Resonance Imaging (MRI) of the muscles may be performed to confirm the diagnosis, especially in cases where muscle biopsy is inconclusive [13].
  • Electromyography (EMG): EMG tests the electrical patterns of muscles and nerves, which can help identify abnormalities associated with congenital myopathies [6].
  • Nerve conduction studies (NCS): NCS tests the electrical activity of nerves, which can also help confirm the diagnosis.
  • Genetic testing: Genetic testing may be performed to identify specific genetic variants responsible for the different forms of congenital myopathy. This test is often done depending on the results of clinical evaluation and muscle biopsy [13].

It's essential to note that a correct diagnostic approach requires integrating data from these tests, along with clinical evaluations, including a detailed family history, to confirm the diagnosis [8].

Additional Diagnostic Tests

  • Genetic testing
  • Muscle biopsy
  • Electromyography (EMG)
  • Nerve conduction studies (NCS)
  • MRI of muscles

Treatment

Pharmacological Compounds Used in Congenital Myopathies

Several types of congenital myopathies are treated with pharmacological compounds that target specific pathways, including the neuromuscular junction (NMJ) and the mTOR pathway.

  • AchEI and agonist of β2R: These compounds target the NMJ, which is responsible for transmitting signals from nerve cells to muscle cells. By targeting this pathway, these drugs can help improve muscle function in individuals with congenital myopathies.
  • Myostatin inhibitor: Myostatin is a protein that regulates muscle growth and development. Inhibiting myostatin has been shown to increase muscle mass and strength in some individuals with congenital myopathies.

These pharmacological compounds are still being researched and developed, but they hold promise for treating various types of congenital myopathies [1][8].

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses of Congenital Myopathy

Congenital myopathy, a rare genetic condition causing muscle weakness, has several differential diagnoses that need to be considered for accurate diagnosis and treatment.

  • Spinal Muscular Atrophy (SMA): A leading differential diagnosis for congenital myopathy, SMA is a genetic disorder affecting the nerve cells responsible for controlling voluntary muscle movement.
  • Muscular Dystrophy: Another important differential diagnosis, muscular dystrophy is a group of inherited disorders characterized by progressive muscle weakness and degeneration.
  • Congenital Myasthenic Syndrome (CMS): A rare genetic disorder causing severe muscle weakness, CMS is often considered in the differential diagnosis of congenital myopathy.
  • Pompe Disease: A genetic disorder caused by the accumulation of glycogen in muscles, Pompe disease can also be a differential diagnosis for congenital myopathy.

These differential diagnoses are crucial to consider when diagnosing and treating congenital myopathy, as they may require different treatment approaches. [8][3][5]

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4163
owl#annotatedSource
t361623
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0081342
core#notation
DOID:0081342
oboInOwl#hasDbXref
MIM:618654
rdf-schema#label
congenital myopathy 8
IAO_0000115
A congenital myopathy that is characterized by hypotonia and delayed motor development apparent from infancy or childhood, resulting in difficulties walking or loss of ambulation within the first few decades and that has_material_basis_in heterozygous mutation in the ACTN2 gene on chromosome 1q43. Heterozygous mutation in the ACTN2 gene can also cause distal myopathy-6 (MPD6), which shows later onset and is less severe.
rdf-schema#subClassOf
t361844
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/G71.29
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.